< Back to situations

[ORGANIZATION]

University Hospital Bonn

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [DE]

Weekly HIV pill trial results

2 clusters · 4 sources · last updated

Latest: Weekly HIV Tablet Matches Daily Regimen in International Trial

In late July, Gilead Sciences and Merck announced that their experimental once‑weekly HIV tablet—combining Merck’s islatravir with Gilead’s lenacapavir—produced undetectable viral loads in two late‑stage trials of adults

[ACTIVE] [HEALTH] [US]

German glioma vaccine development

2 clusters · 7 sources · last updated

Latest: IDH1 Glioma Vaccine Shows 8-Year Survival; New Core2Edge Model Maps Tumor Infiltration

In early July 2026 German cancer researchers announced promising results from an experimental vaccine targeting aggressive brain tumors. By the end of the month, detailed findings from a phase‑1 trial of an IDH1‑mutant g